Cargando…

POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE

Detalles Bibliográficos
Autores principales: FREITAS, M., Francisco, J., Beirão, B., Pereira, P., Sousa, C., Oliveira, L., Morgado, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854956/
http://dx.doi.org/10.1016/j.ekir.2022.01.980
_version_ 1784653548285329408
author FREITAS, M.
Francisco, J.
Beirão, B.
Pereira, P.
Sousa, C.
Oliveira, L.
Morgado, T.
author_facet FREITAS, M.
Francisco, J.
Beirão, B.
Pereira, P.
Sousa, C.
Oliveira, L.
Morgado, T.
author_sort FREITAS, M.
collection PubMed
description
format Online
Article
Text
id pubmed-8854956
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88549562022-02-18 POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE FREITAS, M. Francisco, J. Beirão, B. Pereira, P. Sousa, C. Oliveira, L. Morgado, T. Kidney Int Rep Article Published by Elsevier Inc. 2022-02 2022-02-18 /pmc/articles/PMC8854956/ http://dx.doi.org/10.1016/j.ekir.2022.01.980 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
FREITAS, M.
Francisco, J.
Beirão, B.
Pereira, P.
Sousa, C.
Oliveira, L.
Morgado, T.
POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE
title POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE
title_full POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE
title_fullStr POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE
title_full_unstemmed POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE
title_short POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE
title_sort pos-940 antibody response to pfizer bnt162b2 vaccine in hemodialysis patients: the previous sars-cov-2 infection influence
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854956/
http://dx.doi.org/10.1016/j.ekir.2022.01.980
work_keys_str_mv AT freitasm pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence
AT franciscoj pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence
AT beiraob pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence
AT pereirap pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence
AT sousac pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence
AT oliveiral pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence
AT morgadot pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence